A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy.
Phase of Trial: Phase III
Latest Information Update: 27 Jan 2011
At a glance
- Drugs Topiramate (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 19 Jul 2010 Actual initiation date (Feb 2001) added as reported by ClinicalTrials.gov.
- 19 Jul 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.